Evogene Ltd.
EVGN
Revenue
8.51M
▲2.87M▲50.90%
12 Months ChangeAssets
39.86M
▼-1.10M▼-2.69%
6 Months ChangeLiabilities
25.03M
▲2.61M▲11.64%
12 Months ChangeFree Cash Flow
-20.33M
▲2.04M▲9.10%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-03-28
Form 20-F
ID: 0001178913-24-001137
2023-03-30
Form 20-F
ID: 0001178913-23-001224
2022-03-31
Form 20-F
ID: 0001178913-22-001337
2021-04-02
Form 20-F
ID: 0001178913-21-001263
2020-04-27
Form 20-F
ID: 0001178913-20-001229
2019-04-29
Form 20-F
ID: 0001178913-19-001243
2018-03-30
Form 20-F
ID: 0001178913-18-001042
2017-04-28
Form 20-F
ID: 0001178913-17-001247
2016-04-25
Form 20-F
ID: 0001178913-16-005166
2015-04-30
Form 20-F
ID: 0001178913-15-001382